Assay and other reactions involving droplets
US-2015353999-A1 · Dec 10, 2015 · US
US9797010B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9797010-B2 |
| Application number | US-80912008-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 19, 2008 |
| Priority date | Dec 21, 2007 |
| Publication date | Oct 24, 2017 |
| Grant date | Oct 24, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to systems and methods for sequencing nucleic acids, including sequencing nucleic acids in fluidic droplets. In one set of embodiments, the method employs sequencing by hybridization using droplets such as microfluidic droplets. In some embodiments, droplets are formed which include a target nucleic acid, a nucleic acid probe, and at least one identification element, such as a fluorescent particle. The nucleic acid probes that hybridize to the target nucleic acid are determined, in some instances, by determining the at least one identification element. The nucleic acid probes that hybridize to the target nucleic acid may be used to determine the sequence of the target nucleic acid. In certain instances, the microfluidic droplets are provided with reagents that modify the nucleic acid probe. In some cases, a droplet, such as those described above, is deformed such that the components of the droplets individually pass a target area.
Opening claim text (preview).
What is claimed is: 1. A method, comprising: providing a first microfluidic droplet containing a nucleic acid probe and at least three distinguishable identification elements, wherein each of the at least three distinguishable identification elements is associated with a different oligonucleotide sequence comprising at least one universal nucleic acid residue; providing a second microfluidic droplet comprising a target nucleic acid; and fusing at least some of the fluid in the first fluidic droplet and at least some of the fluid in the second microfluidic droplet to form a fused droplet. 2. The method of claim 1 , comprising determining a sequence of at least a portion of the target nucleic acid. 3. The method of claim 1 , further comprising determining at least a portion of the target nucleic acid by determining at least one of the at least three identification elements contained within the fused droplet. 4. The method of claim 1 , further comprising determining at least one of the at least three identification elements. 5. The method of claim 1 , wherein the nucleic acid probe contains at least four residues. 6. The method of claim 1 , wherein the nucleic acid probe contains at least one locked nucleic acid residue. 7. The method of claim 1 , further comprising determining association between the target nucleic acid and the nucleic acid probe. 8. The method of claim 1 , wherein the nucleic acid probe comprises a quencher. 9. The method of claim 1 , wherein the droplet contains four distinguishable identification elements. 10. The method of claim 1 , wherein each of the at least three distinguishable identification elements is attached to the different oligonucleotide sequence. 11. The method of claim 1 , wherein the first microfluidic droplet or the second microfluidic droplet comprises a ligase. 12. The method of claim 11 , further comprising ligating the nucleic acid probe to one of the different oligonucleotide sequences associated with one of the at least three distinguishable identification elements. 13. The method of claim 1 , wherein each of the different oligonucleotide sequences differs by one nucleic acid residue. 14. The method of claim 13 , wherein the one nucleic acid residue is at the same location on each of the different oligonucleotide sequences. 15. The method of claim 1 , wherein each of the different oligonucleotide sequences has a single non-universal nucleic acid residue. 16. A method, comprising: providing a first microfluidic droplet containing a nucleic acid probe and at least three distinguishable identification elements, wherein each distinguishable identification element is associated with a different oligonucleotide sequence; providing a second microfluidic droplet comprising a target nucleic acid; fusing at least some of the fluid in the first fluidic droplet and at least some of the fluid in the second microfluidic droplet to form a fused droplet; and ligating the nucleic acid probe to one of the different oligonucleotide sequences associated with one of the at least three distinguishable identification elements. 17. The method of claim 16 , comprising determining a sequence of at least a portion of the target nucleic acid. 18. The method of claim 16 , further comprising determining at least a portion of the target nucleic acid by determining at least one of the at least three identification elements contained within the fused droplet. 19. The method of claim 16 , wherein each of the at least three distinguishable identification elements is attached to the different oligonucleotide sequence. 20. The method of claim 16 , wherein each of the different oligonucleotide sequences differs by one nucleic acid residue.
involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title
Particles, e.g. beads · CPC title
Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.